Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese.

Hekun Liu,Sizhong Zhang,Jianyin Lin,Hai Li,Aimin Huang,Cuiying Xiao,Xuefei Li,Zhiguang Su,Chunting Wang,Daniel W Nebert,Bing Zhou,Keqin Zheng,Jiajun Shi,Guixin Li,Dejia Huang

DOI: https://doi.org/10.1016/j.metabol.2004.11.009

IF: 13.934

2005-01-01

Metabolism

Abstract:The recently discovered apolipoprotein A5 (APOA5) gene has been shown to be important in determining plasma triglyceride levels, a major cardiovascular disease risk factor. We searched for possible associations of the APOA5 gene polymorphisms S19W and −1131T>C with coronary heart disease (CHD) in a Chinese population. A total of 483 Chinese CHD patients and 502 control non-CHD subjects were genotyped by polymerase chain reaction–restriction fragment length polymorphism for these 2 single nucleotide polymorphisms. We found that the minor allele 19W was observed only in CHD patients and not in controls, with allelic frequencies of 0.047 and 0.000, respectively (P < .000001), and the minor allele −1131C was significantly higher in CHD patients than in controls (0.391 vs 0.299, P < .0001). These results suggest that both the S19W and −1131T>C variations in the APOA5 gene are associated with the CHD and appear to be 2 genetic risk factors for CHD susceptibility in Chinese. Moreover, we found that triglyceride levels were significantly higher in −1131C carriers than in −1131T subjects of the control group and that high-density–lipoprotein cholesterol was decreased in −1131C carriers among CHD patients.